✦ LIBER ✦

The number of rounds needed to exchange information within a graph

✍ Scribed by Susan F. Assmann; Daniel J. Kleitman

Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 446 KB
Volume: 6
Category: Article
ISSN: 0166-218X
DOI: 10.1016/0166-218x(83)90065-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The average number of registers needed t

The average number of registers needed to evaluate a binary tree optimally

✍ R. Kemp 📂 Article 📅 1979 🏛 Springer-Verlag 🌐 English ⚖ 334 KB

A bound on the number of integrators nee

A bound on the number of integrators needed to linearize a control system

✍ W.M. Sluis; D.M. Tilbury 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 479 KB

A counterexample to a conjecture on the

A counterexample to a conjecture on the bondage number of a graph

✍ Ulrich Teschner 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 113 KB

The bondage number h(G) of a nonempty graph G was first introduced by Fink, Jacobson, Kinch and Roberts in [3]. They generalized a former approach to domination-critical graphs, In their publication they conjectured that b(G)<d(G)+ 1 for any nonempty graph G.

Multiple-dosing drug kinetics: Nomograph

Multiple-dosing drug kinetics: Nomographic method of estimating the number of doses needed to approach within a fixed percent of asymptotic minimum drug level

✍ Berton E. Ballard; Efraim Menczel 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB

Letters to the editor on the number of t

Letters to the editor on the number of trees in a ladder graph

✍ David E. Johnson; Johnny R. Johnson 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

The place of memantine in the treatment

The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis

✍ Gill Livingston; Cornelius Katona 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## Introduction Memantine is currently the only treatment approved for moderately severe to severe Alzheimer's disease (AD). There is still some discussion as to its place in clinical practice and many UK clinicians are discouraged for economic reasons from prescribing it. We adopt a ‘